Human cytomegalovirus load in plasma and bronchoalveolar lavage fluid: A longitudinal study of lung transplant recipients

Journal of Infectious Diseases

Volumn 190, Issue 6, 2004, Pages 1076-1083

  Westall, Glen P ^a   Michaelides, Alexandra ^a   Williams, Trevor J ^a   Snell, Greg I ^a   Kotsimbos, Thomas C ^a,b  

^a MONASH UNIVERSITY MEDICAL SCHOOL   (Australia)

^b ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; VIRUS DNA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BRONCHOSCOPY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT REJECTION; HISTOLOGY; HUMAN; HUMAN CYTOMEGALOVIRUS; LUNG LAVAGE; LUNG TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE; VIRUS LOAD;

ADOLESCENT; ADULT; BIOPSY; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; GRAFT REJECTION; HUMANS; INCLUSION BODIES, VIRAL; LONGITUDINAL STUDIES; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PLASMA; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TIME FACTORS; VIRAL LOAD;

EID: 4444322292     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/422327     Document Type: Article

References (17)

1. Boeckh M, Boivin G. Quantitation of cytomegalovirus: methodologic aspects and clinical applications. Clin Microbiol Rev 1998; 11:533-54.
2. Emery VC, Sabin CA, Cope AV, Gor D, Hassan-Walker AF, Griffiths PD. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 2000; 355:2032-6.
3. Gutierrez CA, Chaparro C, Krajden M, Winton T, Kesten S. Cytomegalovirus viremia in lung transplant recipients receiving ganciclovir and immune globulin. Chest 1998; 113:924-32.
4. Cagle PT, Buffone G, Holland VA, et al. Semiquantitative measurement of cytomegalovirus DNA in lung and heart-lung transplant patients by in vitro DNA amplification. Chest 1992; 101:93-6.
5. Yousem SA, Berry GJ, Cagle PT, et al. Revision of the 1990 working formulation of the classification of pulmonary allograft rejection. Lung Rejection Study Group. J Heart Lung Transplant 1996; 15:1-15.
6. Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002; 34:1094-7.
7. Kotsimbos ATC, Sinickas V, Glare EM, et al. Quantitative detection of human cytomegalovirus DNA in lung transplant recipients. Am J Respir Crit Care Med 1997; 156:1241-6.
8. Michaelides AE, Facey D, Spelman DW, Wesselingh SL, Kotsimbos TC. HCMV DNA detection and quantitation in the plasma and PBL of lung transplant recipients: Cobas Amplicor HCMV monitor test versus in-house quantitative HCMV PCR. J Clin Virol 2003; 28:111-20.
9. Sanchez JL, Kruger RM, Paranjothi S, et al. Relationship of cytomegalovirus viral load in blood to pneumonitis in lung transplant recipients. Transplantation 2001; 72:733-5.
10. Westall GP, Michaelides AE, Williams TJ, Snell GI, Kotsimbos TC. Post lung transplant bronchiolitis obliterans syndrome and early human cytomegalovirus DNAaemia dynamics. Transplantation 2003; 75:2064-8.
11. Bailey TC, Buller RS, Ettinger NA, et al. Quantitative analysis of cytomegalovirus viremia in lung transplant recipients. J Infect Dis 1995; 171:1006-10.
12. Riise GC, Andersson R, Bergstrom T, Lundmark A, Nilsson FN, Olofsson S. Quantification of cytomegalovirus DNA in BAL fluid: a longitudinal study in lung transplant recipients. Chest 2000; 118:1653-60.
13. Falagas ME, Snydman DR. Recurrent cytomegalovirus disease in solid-organ transplant recipients. Transplant Proc 1995; 27:34-7.
14. Stephan F, Fajac A, Grenet A, et al. Predictive value of cytomegalovirus DNA detection by polymerase chain reaction in blood and bronchoalveolar lavage in lung transplant patients. Transplantation 1997; 63:1430-5.
15. Humar A, Uknis M, Carlone-Jambor C, Grussner RW, Dunn DL, Matas A. Cytomegalovirus disease recurrence after ganciclovir treatment in kidney and kidney-pancreas transplant recipients. Transplantation 1999; 67:94-7.
16. Cope AV, Sabin C, Burroughs A, Rolles K, Griffiths PD, Emery VC. Interrelationships among quantity of human cytomegalovirus (HCMV) DNA in blood, donor-recipient serostatus, and administration of methylprednisolone as risk factors for HCMV disease following liver transplantation. J Infect Dis 1997; 176:1484-90.
17. Limaye AP, Raghu G, Koelle DM, Ferrenberg J, Huang M-L, Boeckh M. High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy. J Infect Dis 2002; 185:20-7.